BIOFILCHEM

Biofil Chemicals & Pharmaceuticals Share Price

 

 

Start SIP in BIOFILCHEM

Start SIP
Biofil Chemicals & Pharmaceuticals live price: ₹29.03. It opened at ₹29 vs previous close ₹29; intraday high/low: ₹31/₹29. The 50 & 200 DMA stand at ₹32.34/₹38.61.

Biofil Chemicals & Pharmaceuticals Performance

  • Today's Low
  • ₹29
  • Today's High
  • ₹31
  • 52 Week Low
  • ₹28
  • 52 Week High
  • ₹57
  • Open Price₹29
  • Previous Close₹29
  • Volume15,532
  • 50 DMA₹32.34
  • 100 DMA₹34.50
  • 200 DMA₹38.61

Investment Returns

  • Over 1 Month -10.81%
  • Over 3 Month -13.39%
  • Over 6 Month -30.13%
  • Over 1 Year -36.32%

Smart Investing Starts Here Start SIP with Biofil Chemicals & Pharmaceuticals for Steady Growth!

Invest Now

Biofil Chemicals & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 17
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 47
  • P/B Ratio
  • 2.2
  • Average True Range
  • 1.83
  • EPS
  • 1.7
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.14
  • RSI
  • 38.58
  • MFI
  • 37.94

Biofil Chemicals & Pharmaceuticals Financials

Biofil Chemicals & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹29.03
+ 0.38 (1.33%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹30.59
  • 50 Day
  • ₹32.34
  • 100 Day
  • ₹34.50
  • 200 Day
  • ₹38.61

Resistance and Support

29.48 Pivot Speed
  • R3 32.10
  • R2 31.38
  • R1 30.20
  • S1 28.30
  • S2 27.58
  • S3 26.40

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Biofil Chemicals & Pharmaceuticals has an operating revenue of Rs. 29.18 Cr. on a trailing 12-month basis. An annual revenue de-growth of -17% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 2% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 31 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 34 indicates it belongs to a strong industry group of Medical-Ethical Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Biofil Chemicals & Pharmaceuticals F&O

Biofil Chemicals & Pharmaceuticals Shareholding Pattern

46.79%
0%
0.04%
38.27%
14.9%

Biofil Chemicals & Pharmaceuticals FAQs

Biofil Chemicals & Pharmaceuticals share price is ₹29 As on 26 March, 2026 | 19:11

The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹47.2 Cr As on 26 March, 2026 | 19:11

The P/E ratio of Biofil Chemicals & Pharmaceuticals is 17 As on 26 March, 2026 | 19:11

The PB ratio of Biofil Chemicals & Pharmaceuticals is 2.2 As on 26 March, 2026 | 19:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23